92 related articles for article (PubMed ID: 30929275)
1. A novel imaging flow cytometry method for the detection of histone H4 acetylation in myeloid cells.
Uitrakul S; Hutton C; Veal GJ; Jamieson D
Eur J Clin Invest; 2019 Jul; 49(7):e13115. PubMed ID: 30929275
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
[TBL] [Abstract][Full Text] [Related]
3. Establishment and application of a flow cytometry-based method for detecting histone acetylation levels.
Li JH; Wang CF; Bai F; Zhuang Y; Mao ZJ; Sun YT
Yi Chuan; 2016 Jun; 38(6):581-587. PubMed ID: 27655319
[TBL] [Abstract][Full Text] [Related]
4. The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines.
Chang YL; Huang LC; Chen YC; Wang YW; Hueng DY; Huang SM
Int J Biochem Cell Biol; 2017 Nov; 92():155-163. PubMed ID: 29017950
[TBL] [Abstract][Full Text] [Related]
5. Methods for the analysis of histone H3 and H4 acetylation in blood.
Rigby L; Muscat A; Ashley D; Algar E
Epigenetics; 2012 Aug; 7(8):875-82. PubMed ID: 22772164
[TBL] [Abstract][Full Text] [Related]
6. Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study.
Chavez-Blanco A; Segura-Pacheco B; Perez-Cardenas E; Taja-Chayeb L; Cetina L; Candelaria M; Cantu D; Gonzalez-Fierro A; Garcia-Lopez P; Zambrano P; Perez-Plasencia C; Cabrera G; Trejo-Becerril C; Angeles E; Duenas-Gonzalez A
Mol Cancer; 2005 Jul; 4(1):22. PubMed ID: 16001982
[TBL] [Abstract][Full Text] [Related]
7. In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates.
Marchion DC; Bicaku E; Daud AI; Sullivan DM; Munster PN
Mol Cancer Ther; 2005 Dec; 4(12):1993-2000. PubMed ID: 16373714
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of VPA on multiple myeloma U266 cell proliferation and regulation of histone acetylation].
Zhu YF; Ye BG; Shen JZ; Lin CM; Lin FA; Shen SF; Xu CB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):638-41. PubMed ID: 20561418
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Effect of the Histone Deacetylase Inhibitor Valproic Acid on Viability and Apoptosis of the PLC/PRF5 Human Hepatocellular Carcinoma Cell Line.
Sanaei M; Kavoosi F; Roustazadeh A; Shahsavani H
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2507-2510. PubMed ID: 30256044
[TBL] [Abstract][Full Text] [Related]
10. Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer.
Wittenburg LA; Gustafson DL; Thamm DH
Clin Cancer Res; 2010 Oct; 16(19):4832-42. PubMed ID: 20705615
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide.
Hajji N; Wallenborg K; Vlachos P; Füllgrabe J; Hermanson O; Joseph B
Oncogene; 2010 Apr; 29(15):2192-204. PubMed ID: 20118981
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC.
Munster P; Marchion D; Bicaku E; Lacevic M; Kim J; Centeno B; Daud A; Neuger A; Minton S; Sullivan D
Clin Cancer Res; 2009 Apr; 15(7):2488-96. PubMed ID: 19318486
[TBL] [Abstract][Full Text] [Related]
13. The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver.
Eyal S; Lamb JG; Smith-Yockman M; Yagen B; Fibach E; Altschuler Y; White HS; Bialer M
Br J Pharmacol; 2006 Oct; 149(3):250-60. PubMed ID: 16894351
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers.
Wheler JJ; Janku F; Falchook GS; Jackson TL; Fu S; Naing A; Tsimberidou AM; Moulder SL; Hong DS; Yang H; Piha-Paul SA; Atkins JT; Garcia-Manero G; Kurzrock R
Cancer Chemother Pharmacol; 2014 Mar; 73(3):495-501. PubMed ID: 24435060
[TBL] [Abstract][Full Text] [Related]
15. High content analysis of histone acetylation in human cells and tissues.
Narayan PJ; Dragunow M
J Neurosci Methods; 2010 Oct; 193(1):54-61. PubMed ID: 20817035
[TBL] [Abstract][Full Text] [Related]
16. Effect of valproic acid in comparison with vorinostat on cell growth inhibition and apoptosis induction in the human colon cancer SW48 cells in vitro.
Sanaei M; Kavoosi F; Mansoori O
Exp Oncol; 2018 Jun; 40(2):95-100. PubMed ID: 29949538
[TBL] [Abstract][Full Text] [Related]
17. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.
Shen HY; Kalda A; Yu L; Ferrara J; Zhu J; Chen JF
Neuroscience; 2008 Dec; 157(3):644-55. PubMed ID: 18848971
[TBL] [Abstract][Full Text] [Related]
18. New method to detect histone acetylation levels by flow cytometry.
Ronzoni S; Faretta M; Ballarini M; Pelicci P; Minucci S
Cytometry A; 2005 Jul; 66(1):52-61. PubMed ID: 15915507
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
Takai N; Desmond JC; Kumagai T; Gui D; Said JW; Whittaker S; Miyakawa I; Koeffler HP
Clin Cancer Res; 2004 Feb; 10(3):1141-9. PubMed ID: 14871994
[TBL] [Abstract][Full Text] [Related]
20. Effects of histone deacetylase inhibitors on regenerative cell responses in human dental pulp cells.
Luo Z; Wang Z; He X; Liu N; Liu B; Sun L; Wang J; Ma F; Duncan H; He W; Cooper P
Int Endod J; 2018 Jul; 51(7):767-778. PubMed ID: 28375564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
